Search Count: 4
 |
Crystal Structure Of The Catalytic Domain Of Human Pde5A Complexed With 2-(3-Chlorobenzyl)-4-Oxo-3,4-Dihydroquinazoline-7-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.46 Å Release Date: 2025-01-22 Classification: HYDROLASE Ligands: A1D5K, ZN, MG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: A1D5K, ZN, MG
 |
Crystal Structure Of The Catalytic Domain Of Human Pde10A Complexed With (2-((4-(5-(2-Methylpyridin-4-Yl)-3-(Trifluoromethyl)-1H-Pyrazol-1-Yl)Phenoxy)Methyl)Quinolin-4-Yl)(2,6-Diazaspiro[3.3]Heptan-2-Yl)Methanone
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2025-01-15 Classification: HYDROLASE Ligands: A1LWO, ZN, MG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-15
Ligands: A1LWO, ZN, MG
 |
Rational Design Of Highly Selective Pde5 Inhibitors For The Treatment Of Idiopathic Pulmonary Fibrosis
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2024-10-02 Classification: HYDROLASE/INHIBITOR Ligands: WD3, ZN, MG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-10-02
Ligands: WD3, ZN, MG
 |
Rational Design Of Highly Selective Pde5 Inhibitors For The Treatment Of Idiopathic Pulmonary Fibrosis
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2024-10-02 Classification: HYDROLASE/INHIBITOR Ligands: WDB, ZN, MG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-10-02
Ligands: WDB, ZN, MG